‘Why Biology Is Not Destiny’: An Exchange
By Kathryn Paige Harden et al.,
The New York Review
| 05. 25. 2022
Kathryn Paige Harden, Nick Patterson, Victor I. Reus, and Henry D. Schlinger Jr., reply by M.W. Feldman and Jessica Riskin
In response to:
Why Biology Is Not Destiny from the April 21, 2022 issue
To the Editors:
Marcus Feldman and Jessica Riskin did not like my book. Or rather, they did not like a book called The Genetic Lottery by an author named “Kathryn Paige Harden,” but their review [NYR, April 21] so badly distorts my arguments that I have the curious impression that Feldman and Riskin somehow got their hands on another book entirely, an evil doppelgänger to mine. Therapists, parents, and the unhappily married would recognize the feeling I had upon reading their review the first time: it’s both vexing and bewildering when someone is spoiling for a fight about something you never said.
As a longtime reader of The New York Review of Books, I am surprised and disappointed that this review was published in such an esteemed outlet. Yes, “we all enjoy an intemperate paragraph of syntactically inspired bile,” to quote Zadie Smith, and Feldman and Riskin do deliver the bile. But I assume that, besides wanting to be entertained by vitriol...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...